This week, we interview Amir Abolfathi. Amir is an experienced innovator and medical device executive with a proven record of building and scaling successful enterprises.
He was a founding team member of uLab Systems, Tusker Medical (acquired by Smith and Nephew), and Sonitus Medical. Amir also served for 6 years as an Officer and Vice President of R&D at Align Technology Inc. (NASDAQ: ALGN), the creator of a unique, invisible orthodontic product. Previously, Amir was the first member of the senior management team at Embolic Protection Inc. (acquired by Boston Scientific), where he was a consulting VP of Operations. In early 1995, Amir co-founded EndoTex Interventional Systems (acquired by Boston Scientific), developers of minimally invasive solutions for the treatment of carotid artery disease.
Demonstrated strength in capital strategy and fundraising, with over $280M raised since 2006 and prior contributions to securing $300M from 1995 to 2006, supported by deep venture capital, banking, and strategic partnership networks. Inventor of more than 100 issued patents, with significant contributions in M&A, IPOs, and corporate spin-offs. Served as a public officer of a publicly traded company, bringing broad governance, compliance, and investor relations expertise.
Currently, focusing on executive mentorship and board leadership, guiding entrepreneurs and next-generation executives to realize their vision, while serving as a trusted advisor and executive coach.
